ImmunoPrecise jumps after AI peptides beat semaglutide in lab tests

ReutersJun 12, 2025 12:27 PM

View all comments（0）



Shares of biotech firm ImmunoPrecise Antibodies IPA.O rise 17.5% to $70 premarket

IPA says it has used AI to design new peptides that are as effective as or better than semaglutide, a popular drug for treating diabetes, in lab test

Two of their five engineered peptides matched or exceeded semaglutide's performance in receptor activation tests

Co's proprietary tech, called HYFT and LENSai, uses mathematical patterns to design peptides that are stable, effective and biologically active

IPA says it is planning to test the peptides in animal models and explore different ways of delivering them to patients, such as injections or skin patches

Semaglutide, sold by Danish drugmaker Novo Nordisk NOVOb.CO, is the active ingredient in Ozempic and Wegovy to treat diabetes and obesity

As of last close, IPA's stock was up 45.8% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today

TradingKey - Wall Street is navigating a two-day inflation gauntlet. Tuesday's CPI print for April arrived hotter than expected, rattling equity markets from telehealth to nuclear energy. Wednesday morning brings the Producer Price Index (PPI) for April — and if today's Consumer Price Index is any g

Will US April PPI Ease Inflationary Pressure? Short-Term Forecasts for US Stocks, Dollar and Gold

TradingKey - The U.S. is set to release April PPI data at 8:30 AM ET on May 13. Markets widely expect the U.S. April PPI to continue its upward trend, with the consensus pointing to a year-on-year growth rate of 4.9%, up from 4.0% in March. If realized, concerns regarding the upstream transmission of inflationary pressures will further intensify.

Samsung’s Largest Strike in History: Can SK Hynix and Micron Sit Back and Reap the Benefits?

TradingKey - On May 21, 61,000 union members at Samsung Electronics will launch an 18-day general strike, following a 93.1% approval vote. Government mediation between labor and management has collapsed.

Japan and South Korea Stocks Open Lower, Samsung Strike Storm and Higher-Than-Expected Inflation Disrupt Markets

TradingKey - On May 13, the Nikkei 225 Index opened 0.5% lower, while South Korea’s KOSPI Index opened down 1.7% before losses further widened to 3%.

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

TradingKey - Cerebras Systems (CBRS) IPO prices May 13–14 at $125–$135/share. $26–$27B valuation, 20x oversubscribed, $510M revenue, 47% net margin, OpenAI 750MW deal. Everything you need to know.

Featured Tools